Compare Ionis Pharmaceuticals Inc. Common Stock (IONS) vs Progressive Corp (PGR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ionis Pharmaceuticals Inc. Common Stock vs Progressive Corp — how do they compare? Ionis Pharmaceuticals Inc. Common Stock trades at $43.2 (market cap $7.04B), while Progressive Corp trades at $215.56 (market cap $123.89B). The key difference: Progressive Corp is far larger — about 17.6× Ionis Pharmaceuticals Inc. Common Stock's market cap, and Progressive Corp pays a 0.19% dividend while Ionis Pharmaceuticals Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Ionis Pharmaceuticals Inc. Common Stock for 0 Days and Progressive Corp for 81 Days on average.
| IONS | PGR | |
|---|---|---|
Market Cap | $7.04B | $123.89B |
Volume | 2,977,440 | 7,205,217 |
Sector | Health | Financials |
52-Week High | $86.50 | $236.18 |
52-Week Low | $42.38 | $190.40 |
Typical Hold Time | 0 Days | 81 Days |
Enterprise Value | $6.60B | $132.10B |
Dividend Yield | — | 0.19% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Progressive Corporation (PGR) trades at $222.88, up 1.18% with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamentals with $87.6B revenue (2025), 12.85% net margin, and attractive valuation at 11.18 P/E. Recent earnings show mixed quarterly performance with two beats and two misses, while cash flow remains stable with $17.55B operating cash flow.
Outlook remains positive with analyst consensus at $222.23 target and 38% buy ratings, though competition in personal auto insurance presents headwinds. The stock's current proximity to resistance at $222 suggests potential consolidation, while strong ROE of 34.94% supports long-term growth potential despite elevated RSI levels indicating overbought conditions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ionis Pharmaceuticals Inc. Common Stock
Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.
Read more on IONS →About Progressive Corp
Progressive underwrites private and commercial auto insurance and specialty lines
Read more on PGR →
